These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 16005609)

  • 1. Efficacy of clonal deletion vs. anergy of self-reactive CD4 T-cells for the prevention and reversal of autoimmune diabetes.
    Preda-Pais A; Stan AC; Casares S; Bona C; Brumeanu TD
    J Autoimmun; 2005 Aug; 25(1):21-32. PubMed ID: 16005609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-regulation of diabetogenic CD4+ T cells by a soluble dimeric peptide-MHC class II chimera.
    Casares S; Hurtado A; McEvoy RC; Sarukhan A; von Boehmer H; Brumeanu TD
    Nat Immunol; 2002 Apr; 3(4):383-91. PubMed ID: 11862219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantigen-independent deletion of diabetogenic CD4+ thymocytes by protective MHC class II molecules.
    Schmidt D; Amrani A; Verdaguer J; Bou S; Santamaria P
    J Immunol; 1999 Apr; 162(8):4627-36. PubMed ID: 10202002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of type 1 diabetes by a new MHC II-peptide chimera: "Single-epitope-mediated suppression" to stabilize a polyclonal autoimmune T-cell process.
    Lin M; Stoica-Nazarov C; Surls J; Kehl M; Bona C; Olsen C; Brumeanu TD; Casares S
    Eur J Immunol; 2010 Aug; 40(8):2277-88. PubMed ID: 20540111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thymic positive selection and peripheral activation of islet antigen-specific T cells: separation of two diabetogenic steps by an I-A(g7) class II MHC beta-chain mutant.
    Kanagawa O; Vaupel BA; Xu G; Unanue ER; Katz JD
    J Immunol; 1998 Nov; 161(9):4489-92. PubMed ID: 9794372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of central T cell tolerance: recombinant antibodies deliver peptides for deletion of antigen-specific (CD4+)8+ thymocytes.
    Schjetne KW; Thommesen JE; Fredriksen AB; Lunde E; Sandlie I; Bogen B
    Eur J Immunol; 2005 Nov; 35(11):3142-52. PubMed ID: 16184515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A model for antigen-specific T-cell anergy: displacement of CD4-p56(lck) signalosome from the lipid rafts by a soluble, dimeric peptide-MHC class II chimera.
    Thomas S; Kumar R; Preda-Pais A; Casares S; Brumeanu TD
    J Immunol; 2003 Jun; 170(12):5981-92. PubMed ID: 12794125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two mechanisms for the non-MHC-linked resistance to spontaneous autoimmunity.
    Verdaguer J; Amrani A; Anderson B; Schmidt D; Santamaria P
    J Immunol; 1999 Apr; 162(8):4614-26. PubMed ID: 10202001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disruption of the STAT4 signaling pathway protects from autoimmune diabetes while retaining antiviral immune competence.
    Holz A; Bot A; Coon B; Wolfe T; Grusby MJ; von Herrath MG
    J Immunol; 1999 Nov; 163(10):5374-82. PubMed ID: 10553062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A peptide-major histocompatibility complex II chimera favors survival of pancreatic beta-islets grafted in type 1 diabetic mice.
    Casares S; Lin M; Zhang N; Teijaro JR; Stoica C; McEvoy R; Farber DL; Bona C; Brumeanu TD
    Transplantation; 2008 Jun; 85(12):1717-25. PubMed ID: 18580462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in sensitivity of peripheral lymphocytes of autoimmune gld mice to FasL-mediated apoptosis reveal a mechanism for the preferential deletion of CD4-CD8-B220+ T cells.
    Xiao S; Zhang X; Mann KK; Jodo S; Li L; Jarjour WN; Marshak-Rothstein A; Sherr DH; Ju ST
    Int Immunol; 2004 May; 16(5):759-66. PubMed ID: 15096479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T-cell tolerance induced by repeated antigen stimulation: selective loss of Foxp3- conventional CD4 T cells and induction of CD4 T-cell anergy.
    Eroukhmanoff L; Oderup C; Ivars F
    Eur J Immunol; 2009 Apr; 39(4):1078-87. PubMed ID: 19283777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential susceptibility of naïve versus cloned CD4+ T cells to antigen-specific and MHC-restricted anergy induction.
    Liu QS; Zhang RH; Chu YW; Xiong SD
    Sheng Li Xue Bao; 2003 Dec; 55(6):633-40. PubMed ID: 14695478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Despite efficient intrathymic negative selection of host-reactive T cells, autoimmune disease may develop in porcine thymus-grafted athymic mice: evidence for failure of regulatory mechanisms suppressing autoimmunity.
    Zhao Y; Rodriguez-Barbosa JI; Shimizu A; Sachs DH; Sykes M
    Transplantation; 2003 Jun; 75(11):1832-40. PubMed ID: 12811242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of acquired thymic tolerance in vivo: intrathymic injection of antigen induces apoptosis of thymocytes and peripheral T cell anergy.
    Chen W; Sayegh MH; Khoury SJ
    J Immunol; 1998 Feb; 160(3):1504-8. PubMed ID: 9570573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of retinal pigmented epithelial cells and CD4 T cells leads to T-cell anergy.
    Gregerson DS; Heuss ND; Lew KL; McPherson SW; Ferrington DA
    Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4654-63. PubMed ID: 17898289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigen-specific downregulation of T cells by doxorubicin delivered through a recombinant MHC II--peptide chimera.
    Casares S; Stan AC; Bona CA; Brumeanu TD
    Nat Biotechnol; 2001 Feb; 19(2):142-7. PubMed ID: 11175728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection against diabetes by MHC heterozygosity and reversal by cyclophosphamide.
    Wu AY; Schulman SJ; Marconi LA; Reilly CR; Scott B; Lo D
    Cell Immunol; 1998 Mar; 184(2):112-20. PubMed ID: 9630837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble, dimeric HLA DR4-peptide chimeras: an approach for detection and immunoregulation of human type-1 diabetes.
    Preda I; McEvoy RC; Lin M; Bona CA; Rapaport R; Brumeanu TD; Casares S
    Eur J Immunol; 2005 Sep; 35(9):2762-75. PubMed ID: 16106371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deficiency in NOD antigen-presenting cell function may be responsible for suboptimal CD4+CD25+ T-cell-mediated regulation and type 1 diabetes development in NOD mice.
    Alard P; Manirarora JN; Parnell SA; Hudkins JL; Clark SL; Kosiewicz MM
    Diabetes; 2006 Jul; 55(7):2098-105. PubMed ID: 16804081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.